Mode
Text Size
Log in / Sign up

olopatadine

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of olopatadine

4 trials tracked of olopatadine: 2 in phase 3 or 4 and 1 with published results. The most-cited published study has 55 citations.

4Trials tracked
2Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 3 2 Other / NA 2
  1. Phase 3 Efficacy and Safety Study of RAGWITEK™ (MK-3641) in Children With Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (MK-3641-008) Completed · 55 cited
  2. Phase 3 AGN-229666 Ophthalmic Solution in Japanese Patients With Allergic Conjunctivitis Completed
  3. N/A Effect of Olopatadine on Allergic Tear Mediators Completed
  4. N/A Olopatadine Eye Drops and Allergy Skin Testing Completed

Showing the 4 most-cited and recently-updated of 4 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.